Systemic and CNS Activity of Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET-Mutant Medullary Thyroid Cancer With Extensive CNS Metastases
Alexander Andreev-Drakhlin, Maria E. Cabanillas, Behrang Amini, Vivek Subbiah
Topics & Concepts
Medullary thyroid cancerMedullary cavityMedicineCancerMutantThyroidThyroid cancerCancer researchNeuroscienceInternal medicineBiologyGeneticsGeneThyroid Cancer Diagnosis and TreatmentLung Cancer Treatments and MutationsRadiomics and Machine Learning in Medical Imaging